Intravenous Ascorbic Acid Infusion Improves Myocardial Perfusion Grade During Elective Percutaneous Coronary Intervention. Relationship With Oxidative Stress Markers

JACC: Cardiovascular Interventions

Volumn 3, Issue 2, 2010, Pages 221-229

  Basili, Stefania ^a   Tanzilli, Gaetano ^a   Mangieri, Enrico ^a   Raparelli, Valeria ^a   Di Santo, Serena ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

corrected TIMI frame count; myocardial perfusion; oxidative stress; percutaneous coronary intervention; periprocedural myocardial injury; TIMI myocardial perfusion grade

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; ANTIOXIDANT; ASCORBIC ACID; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG MECHANISM; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATION; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; STATISTICS AS TOPIC; STROKE VOLUME; SURGICAL PROCEDURES, ELECTIVE; VENTRICULAR FUNCTION, LEFT;

EID: 76449086110     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.025     Document Type: Article

References (60)

1. Brener S.J., Ellis S.G., Schneider J., and Topol E.J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 23 (2002) 869-876
2. Prasad A., Singh M., Lerman A., Lennon R.J., Holmes Jr. D.R., and Rihal C.S. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 48 (2006) 1765-1770
3. Nienhuis M.B., Ottervanger J.P., Bilo H.J., Dikkeschei B.D., and Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 71 (2008) 318-324
4. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 26 (2005) 2493-2519
5. Taylor A.J., Al-Saadi N., Abdel-Aty H., et al. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J 151 (2006) 891.e1-891.e7
6. Gibson C.M., Cannon C.P., Daley W.L., et al. The TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
7. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
8. Gibson C.M., Cannon C.P., Murphy S.A., Marble S.J., Barron H.V., Braunwald E., and TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105 (2002) 1909-1913
9. 2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106 (2002) 2901-2907
10. Reilly M.P., Delanty N., Roy L., et al. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96 (1997) 3314-3320
11. Iuliano L., Praticò D., Greco C., et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 37 (2001) 76-80
12. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
13. Jackson T.S., Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83 (1998) 916-922
14. Hornig B., Arakawa A., Kohler C., and Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97 (1998) 363-368
15. Carr A.C., Zhu B.Z., and Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87 (2000) 349-354
16. Cangemi R., Angelico F., Loffredo L., et al. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 43 (2007) 853-859
17. Tousoulis D., Xenakis C., Tentolouris C., et al. Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina. Heart 91 (2005) 1319-1323
18. Hamabe A., Takase B., Uehata A., Kurita A., Ohsuzu F., and Tamai S. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C. Am J Cardiol 87 (2001) 1154-1159
19. Canadian Cardiovascular Society. Canadian Cardiovascular Society grading of angina pectoris. http://www.ccs.ca/download/position_statements/Grading%20of%20Angina.pdf Accessed November 22, 2006
20. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) 216-235
21. Gibson C.M., Murphy S.A., Rizzo M.J., et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation 99 (1999) 1945-1950
22. Maioli M., Bellandi F., Leoncini M., Toso A., and Dabizzi R.P. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI trial). J Am Coll Cardiol 49 (2007) 1517-1524
23. Gibson C.M., Murphy S.A., Marble S.J., et al. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. Am Heart J 143 (2002) 106-110
24. Lee D.P., Herity N.A., Hiatt B.L., et al. TIrofiban Given in the Emergency Room before Primary Angioplasty. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Circulation 107 (2003) 1497-1501
25. Chevalier B., Gilard M., Lang I., et al. Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. EuroIntervention 4 (2008) 222-228
26. McLaughlin M.G., Stone G.W., Aymong E., et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 1215-1223
27. Prasad A., Stone G.W., Stuckey T.D., et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 45 (2005) 508-514
28. Camici P.G., and Crea F. Coronary microvascular dysfunction. N Engl J Med 356 (2007) 830-840
29. Berg K., Wiseth R., Bjerve K., et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 38 (2004) 517-525
30. Inoue T., Kato T., Hikichi Y., et al. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost 95 (2006) 43-48
31. Tsimikas S., Lau H.K., Han K.R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
32. Funayama H., Ishikawa S.E., Sugawara Y., Kubo N., Momomura S.I., and Kawakami M. Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction. Int J Cardiol (2009) Jan 10 [E-pub ahead of print]
33. Baker T.A., Milstien S., and Katusic Z.S. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37 (2001) 333-338
34. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid and thiols: implications for uncoupling endothelial nitric oxide synthase. J Biol Chem 278 (2003) 22546-22554
35. Jourd'heuil D., Jourd'heuil F.L., Kutchukian P.S., Musah R.A., Wink D.A., and Grisham M.B. Reaction of superoxide and nitric oxide with peroxynitrite: implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem 276 (2001) 28799-28805
36. Carr A., and Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med 28 (2000) 1806-1814
37. Higa O.H., Parra E.R., Ab'Saber A.M., Farhat C., Higa R., and Capelozzi V.L. Protective effects of ascorbic acid pretreatment in a rat model of intestinal ischemia-reperfusion injury: a histomorphometric study. Clinics 62 (2007) 315-320
38. Mack W.J., Mocco J., Ducruet A.F., et al. A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery 59 (2006) 383-388
39. Solzbach U., Hornig B., Jeserich M., and Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96 (1997) 1513-1519
40. Kaufmann P.A., Gnecchi-Ruscone T., di Terlizzi M., Schäfers K.P., Lüscher T.F., and Camici P.G. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102 (2000) 1233-1238
41. Marui N., Offermann M.K., Swerlick R., et al. Vascular cell-adhesion molecule-1 (Vcam-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial-cells. J Clin Invest 92 (1993) 1866-1874
42. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., and Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276 (2001) 40-47
43. Huang A., Vita J.A., Venema R.C., and Keaney J.F. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275 (2000) 17399-17406
44. Hong H.J., Hsiao G., Cheng T.H., and Yen M.H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38 (2001) 1044-1048
45. Landmesser U., Dikalov S., Price S.R., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
46. 2- imbalance in insulin-resistant rat aorta. Diabetes 48 (1999) 2437-2445
47. D'Uscio L.V., Milstien S., Richardson D., Smith L., and Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 92 (2003) 88-95
48. Smith A.R., Visioli F., and Hagen T.M. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J 16 (2002) 1102-1104
49. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic Biol Med 28 (2000) 1421-1429
50. Wu F., Schuster D.P., Tyml K., and Wilson J.X. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic Biol Med 42 (2007) 124-131
51. Papparella I., Ceolotto G., Berto L., et al. Vitamin C prevents zidovudine induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 73 (2007) 432-438
52. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606-611
53. Mohazzab K.M., Kaminski P.M., and Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary-artery endothelium. Am J Physiol 266 (1994) H2568-H2572
54. Delanty N., Reilly M.P., Pratico D., et al. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95 (1997) 2492-2499
55. Kijima Y., Hashimura K., Matsu-ura Y., et al. Transcardiac 8-isoprostaglandin F (2 alpha) generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 64 (2001) 161-166
56. Möbert J., Becker B.F., Zahler S., and Gerlach E. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 29 (1997) 789-794
57. Kromer B.M., and Tippins J.R. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol 119 (1996) 1276-1280
58. Cracowski J.L., Marliere S., and Bessard G. Vasomotor effects and pathophysiologic relevance of F(2)-isoprostane formation in vascular diseases. J Am Coll Cardiol 39 (2002) 554-555
59. Greaves K., Dixon S.R., Coker I.O., et al. Influence of isoprostane F2alpha-III on reflow after myocardial infarction. Eur Heart J 25 (2004) 847-853
60. Padayatty S.J., Sun H., Wang Y., et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 140 (2004) 533-537